Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Reverse transcriptase inhibitors

Sensitive Assessment of the Virologic Outcomes of Stopping and Restarting Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy

Anna Maria Geretti, Zoe Fox, Jeffrey A. Johnson, Clare Booth, Jonathan Lipscomb, Lieven J. Stuyver, Gilda Tachedjian, John Baxter, Giota Touloumi, Clara Lehmann, Andrew Owen, Andrew Phillips, for the INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group

published 18 Jul 2013

Loading metrics information...

Metrics unavailable. Please check back later.

Comparison of Tenofovir, Zidovudine, or Stavudine as Part of First-Line Antiretroviral Therapy in a Resource-Limited-Setting: A Cohort Study

Kavindhran Velen, James J. Lewis, Salome Charalambous, Alison D. Grant, Gavin J. Churchyard, Christopher J. Hoffmann

published 14 May 2013

Loading metrics information...

Metrics unavailable. Please check back later.

Clinical Evaluation of Rega 8: An Updated Genotypic Interpretation System That Significantly Predicts HIV-Therapy Response

Jurgen Vercauteren, Gertjan Beheydt, Mattia Prosperi, Pieter Libin, Stijn Imbrechts, Ricardo Camacho, Bonaventura Clotet, Andrea De Luca, Zehava Grossman, Rolf Kaiser, Anders Sönnerborg, Carlo Torti, Eric Van Wijngaerden, Jean-Claude Schmit, Maurizio Zazzi, Anna-Maria Geretti, Anne-Mieke Vandamme, Kristel Van Laethem

published 17 Apr 2013

Loading metrics information...

Metrics unavailable. Please check back later.

Valproic Acid Inhibits the Release of Soluble CD40L Induced by Non-Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Infected Individuals

Donna C. Davidson, Giovanni Schifitto, Sanjay B. Maggirwar

published 28 Mar 2013

Loading metrics information...

Metrics unavailable. Please check back later.

Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens

Alexandra U. Scherrer, Jürg Böni, Sabine Yerly, Thomas Klimkait, Vincent Aubert, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini, Luigia Elzi, Pietro L. Vernazza, Enos Bernasconi, Bruno Ledergerber, Huldrych F. Günthard, the Swiss HIV Cohort Study (SHCS)

published 26 Nov 2012

Loading metrics information...

Metrics unavailable. Please check back later.

Pharmacologic Boosting of Atazanavir in Maintenance HIV-1 Therapy: The COREYA Propensity-Score Adjusted Study

Laurent Hocqueloux, Philippe Choisy, Gwenaël Le Moal, Françoise Borsa-Lebas, David Plainchamp, Eric Legac, Thierry Prazuck, Xavier de la Tribonnière, Yazdan Yazdanpanah, Jean-Jacques Parienti

published 09 Nov 2012

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-Effectiveness of the Third-Agent Class in Treatment-Naive Human Immunodeficiency Virus-Infected Patients in Portugal

Filipa Aragão, José Vera, Inês Vaz Pinto

published 17 Sep 2012

Loading metrics information...

Metrics unavailable. Please check back later.

Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients

Alexandra U. Scherrer, Bruno Ledergerber, Viktor von Wyl, Jürg Böni, Sabine Yerly, Thomas Klimkait, Cristina Cellerai, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini, Luigia Elzi, Pietro L. Vernazza, Enos Bernasconi, Huldrych F. Günthard, and the Swiss HIV Cohort Study (SHCS)

published 18 Jun 2012

Loading metrics information...

Metrics unavailable. Please check back later.

K65R in Subtype C HIV-1 Isolates from Patients Failing on a First-Line Regimen Including d4T or AZT: Comparison of Sanger and UDP Sequencing Data

Patricia Recordon-Pinson, Jennifer Papuchon, Sandrine Reigadas, Alaka Deshpande, Hervé Fleury

published 16 May 2012

Loading metrics information...

Metrics unavailable. Please check back later.

Impact of Low-Level-Viremia on HIV-1 Drug-Resistance Evolution among Antiretroviral Treated-Patients

Constance Delaugerre, Sébastien Gallien, Philippe Flandre, Dominique Mathez, Rishma Amarsy, Samuel Ferret, Julie Timsit, Jean-Michel Molina, Pierre de Truchis

published 10 May 2012

Loading metrics information...

Metrics unavailable. Please check back later.

Increase of Transmitted Drug Resistance among HIV-Infected Sub-Saharan Africans Residing in Spain in Contrast to the Native Population

Gonzalo Yebra, Miguel de Mulder, María Jesús Pérez-Elías, José Antonio Pérez-Molina, Juan Carlos Galán, Jara Llenas-García, Santiago Moreno, África Holguín

published 25 Oct 2011

Loading metrics information...

Metrics unavailable. Please check back later.

Transmitted Drug Resistance in the CFAR Network of Integrated Clinical Systems Cohort: Prevalence and Effects on Pre-Therapy CD4 and Viral Load

Art F. Y. Poon, Jeannette L. Aldous, W. Christopher Mathews, Mari Kitahata, James S. Kahn, Michael S. Saag, Benigno Rodríguez, Stephen L. Boswell, Simon D. W. Frost, Richard H. Haubrich

published 20 Jun 2011

Loading metrics information...

Metrics unavailable. Please check back later.

Clinical Predictors of Immune Reconstitution following Combination Antiretroviral Therapy in Patients from the Australian HIV Observational Database

Reena Rajasuriar, Maelenn Gouillou, Tim Spelman, Tim Read, Jennifer Hoy, Matthew Law, Paul U. Cameron, Kathy Petoumenos, Sharon R. Lewin

published 02 Jun 2011

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Reverse transcriptase inhibitors

You can change these options by clicking profile then "Alerts and Notifications"